Patent · US Active

Therapy with CD4 binding peptides and radiation

US9309315B2 · kind B2 · utility

2Cited by
11References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 18, 2006
Grant dateApr 12, 2016
Priority date
Expiry dateJul 5, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a peptide, such as an antibody, capable of binding to CD4 and use thereof for the mediation of radiation treatment of a clinical condition. The radiation treatment may for instance by treatment with PUVA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.